1-(o-Tolyl)piperazine hydrochloride → HCID 13729385, Verbindung

HRID 1906442

Reaktionsgleichung

Reaktionsgleichung von HRID 1906442
[C:1]([C:4]1[O:5][C:6]2[C:12]([O:13][CH2:14][CH:15]3[O:17][CH2:16]3)=[CH:11][CH:10]=[CH:9][C:7]=2[CH:8]=1)(=[O:3])[NH2:2].Cl.[CH3:19][C:20]1[CH:25]=[CH:24][CH:23]=[CH:22][C:21]=1[N:26]1[CH2:31][CH2:30][NH:29][CH2:28][CH2:27]1>>[C:1]([C:4]1[O:5][C:6]2[C:12]([O:13][CH2:14][CH:15]([OH:17])[CH2:16][N:29]3[CH2:30][CH2:31][N:26]([C:21]4[CH:22]=[CH:23][CH:24]=[CH:25][C:20]=4[CH3:19])[CH2:27][CH2:28]3)=[CH:11][CH:10]=[CH:9][C:7]=2[CH:8]=1)(=[O:3])[NH2:2]

Komponenten

3

Versuchsvorschrift

The procedures of Example 10 were repeated except that 1.2 g (0.005 mole) of 2-carbamoyl-7-(2,3-epoxypropoxy)benzofuran and 1.2 g (0.0055 mole) of 1-(2-methylphenyl)piperazine hydrochloride were employed. The obtained concentrated residue was crystallized from ethyl acetate and petroleum ether.

Aufarbeitung

  1. customThe obtained concentrated residue was crystallized from ethyl acetate and petroleum ether

Quellen und Nachweise

ORD-Eintrag
ord-c920629ff2c34bcbb35aacb3fe1b01e1
Quelldatensatz
uspto-grants-1987_03
Patentnummer
US04652566

Verknüpfte Notizen

Wird geladen…